Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclic AMP second-messenger signal amplification in depression.

R P Ebstein1, B Lerer, B Shapira

  • 1Jerusalem Mental Health Center, Ezrath Nashim Hospital, Israel.

The British Journal of Psychiatry : the Journal of Mental Science
|May 1, 1988
PubMed
Summary

Depressed patients show reduced beta-adrenergic cyclic AMP response in lymphocytes. This blunted signaling, linked to insomnia and treatment non-response, may involve post-receptor issues in depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secondary rewards acquire enhanced incentive motivation via increasing anticipatory activity of the lateral orbitofrontal cortex.

Brain structure & function·2021
Same author

Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree - CORRIGENDUM.

The international journal of neuropsychopharmacology·2019
Same author

Neuroendocrine stress response is moderated by sex and sex hormone receptor polymorphisms.

Hormones and behavior·2018
Same author

Differential effects of chronic stress in young-adult and old female mice: cognitive-behavioral manifestations and neurobiological correlates.

Molecular psychiatry·2017
Same author

Response to Letter to Editor on "Social impairments among children perinatally exposed to oxytocin or oxytocin receptor antagonist".

Early human development·2017
Same author

Alterations in the expression of a neurodevelopmental gene exert long-lasting effects on cognitive-emotional phenotypes and functional brain networks: translational evidence from the stress-resilient Ahi1 knockout mouse.

Molecular psychiatry·2016

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cellular Biology

Background:

  • Depression is associated with altered cellular signaling pathways.
  • Beta-adrenergic receptor function is implicated in mood regulation.
  • Cyclic AMP (cAMP) is a key second messenger in cellular communication.

Purpose of the Study:

  • To investigate beta-adrenergic-mediated cyclic AMP (cAMP) accumulation in lymphocytes of depressed patients.
  • To compare signaling responses between depressed patients and healthy controls.
  • To explore the relationship between signaling responses, treatment outcomes, and insomnia in depression.

Main Methods:

  • Collected lymphocytes from depressed patients and age/sex-matched controls.
  • Measured beta-adrenergic-stimulated cAMP accumulation in response to isoproterenol.

Related Experiment Videos

  • Assessed the effect of forskolin on cAMP accumulation in a subset of patients.
  • Correlated signaling responses with clinical improvement and insomnia severity.
  • Main Results:

    • Lymphocytes from depressed patients exhibited significantly reduced cAMP accumulation compared to controls.
    • Patients not responding to antidepressant treatment showed lower pretreatment isoproterenol responses than improved patients.
    • Late-night insomnia was significantly associated with blunted beta-adrenergic responses.
    • In patients with the lowest responses, forskolin-stimulated cAMP accumulation was also decreased, indicating post-receptor involvement.

    Conclusions:

    • Reduced beta-adrenergic signaling and cAMP accumulation in lymphocytes are observed in depression.
    • Blunted signaling is linked to poor treatment response and insomnia.
    • Post-receptor mechanisms may contribute to impaired beta-adrenergic signal amplification in depression.